Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eleni Paschou is active.

Publication


Featured researches published by Eleni Paschou.


Scandinavian Journal of Infectious Diseases | 2013

Splenic infarction as a rare complication of infectious mononucleosis due to Epstein–Barr virus infection in a patient with no significant comorbidity: Case report and review of the literature

Eleni Gavriilaki; Nikolaos Sabanis; Eleni Paschou; Savas Grigoriadis; Maria Mainou; Alexandra Gaitanaki; Maria Skargani-Koraka

Abstract We report the case of a 17-y-old boy diagnosed with infectious mononucleosis due to Epstein–Barr virus infection who complained of left upper quadrant pain. A magnetic resonance imaging scan showed a splenic infarct in the enlarged spleen. Other causes of splenic infarction were excluded. Thus, infectious mononucleosis may cause splenic infarction in patients without other comorbidities.


Infectious diseases | 2015

Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder

Nikolaos Sabanis; Eleni Paschou; Eleni Gavriilaki; Sotirios Vasileiou

Abstract A 74-year-old female patient with end-stage renal disease, undergoing periodic hemodialysis, was hospitalized due to infection by multidrug-resistant Acinetobacter baumannii after hip replacement surgery. She was treated with tigecycline, a glycylcycline agent. Subsequently she developed coagulation disorders as substantiated by increased international normalized ratio (INR), prolonged partial thromboplastin time (aPTT), and severe hypofibrinogenemia, followed by transaminasemia, cholestasis, and anemia. Ultrasonography and computed tomography revealed no underlying pathological entities. Tigecycline was discontinued and the patient underwent daily hemodialysis and received multiple fresh frozen plasma transfusions. Additionally, she was treated with colistin. Her clinical and laboratory status improved. We suggest that patients treated with tigecycline should be monitored for changes in INR, aPTT, and fibrinogen levels to avoid severe, life-threatening coagulation disturbances.


Hemodialysis International | 2015

Disseminated tuberculosis: A neglected entity in immunocompromised hemodialysis patients

Eleni Gavriilaki; Nikos Sabanis; Eleni Paschou; Katerina Michalaki; Thomas Zarampoukas

End‐stage renal disease is considered a factor predisposing to increased risk of tuberculosis with frequent extrapulmonary localization. Although extrapulmonary tuberculosis has been observed for decades, disseminated tuberculosis, a major cause of morbidity and mortality in immunocompromised hosts, remains rather neglected. We report an unusual case of an immunocompromised patient with a late diagnosis and delayed treatment of genitourinary tuberculosis that subsequently led to the diagnosis of vertebral and miliary tuberculosis (disseminating tuberculosis). Therefore, increased awareness is warranted from physicians dealing with hemodialysis patients in order to avoid delays in diagnosis and treatment initiation.


Internal Medicine Journal | 2015

B12 deficiency in chronic kidney disease: early recognition matters.

Eleni Gavriilaki; Eleni Paschou; G. Papaioannou; Nikos Sabanis

W, Neubauer D. Functional outcome of children with mitochondrial diseases. Pediatr Neurol 2011; 44: 340–46. 5 Tarnopolsky MA. Exercise as a therapeutic strategy for primary mitochondrial cytopathies. J Child Neurol 2014; 29: 1225–34. 6 Cotelli MS, Vielmi V, Rimoldi M, Rizzetto M, Castellotti B, Bertasi V et al. Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect. Neurol Sci 2012; 33: 1383–87. 7 Grünert SC. Clinical and genetic heterogeneity of late-onset multiple acylcoenzyme A dehydrogenase deficiency. Orphanet J Rare Dis 2014; 9: ll7. 8 Olsen RK, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007; 130: 2045–54. 9 Whitaker CH, Felice KJ, Silvers D, Wu Q. Fulminant lipid storage myopathy due to multiple acyl-coenzyme A dehydrogenase deficiency. Muscle Nerve 2015; 52: 289–93. 10 The AVERT Trial Collaboration Group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet 2015; 386: 46–55.


Case reports in endocrinology | 2015

Rare Skeletal Complications in the Setting of Primary Hyperparathyroidism

Nikos Sabanis; Eleni Gavriilaki; Eleni Paschou; Dimitrios Papanikolaou; Pinelopi Ioannidou; Sotirios Vasileiou

Parathyroid carcinoma represents an extremely rare neoplasm with diverse clinical manifestations which vary from asymptomatic patients to severe complications of hypercalcemia or parathyrotoxicosis while skeletal involvement is rather common. Herein we aimed at presenting a unique case of a young patient with rare aggressive skeletal complications of parathyroid cancer that initially were misdiagnosed. Ossification of the cervical ligamentum flavum and skull tumor illustrates erosive bonny lesions of hyperparathyroidism that in association with previous medical history of recurrent nephrolithiasis and biochemical findings guide the diagnosis. We suggest that increased awareness and holistic approach are needed in order to recognize and further investigate signs and symptoms of hyperparathyroidism.


Case reports in emergency medicine | 2014

An Uncommon Presentation of Spontaneous Rectus Sheath Hematoma with Acute Kidney Injury due to Obstructive Uropathy and Prerenal Azotemia

Eleni Paschou; Eleni Gavriilaki; Maria Mourounoglou; Nikolaos Sabanis

Rectus Sheath Hematoma (RSH) represents an unusual entity which is characterized by acute abdominal pain and tender palpable abdominal mass usually, among elderly patients receiving anticoagulant therapy. We report the case of an 81-year-old woman admitted to our department due to acute abdominal pain and oligoanuria. The patient had recently been hospitalized due to acute myocardial infarction (AMI) and atrial fibrillation (AF) and received both anticoagulant and antiplatelet therapies. The radiological assessments revealed an extended Rectus Sheath Hematoma and bilateral hydronephrosis. Treatment of the hematoma required cessation of anticoagulants and antiplatelet agents, immobilization, blood and fresh frozen plasma transfusion, and administration of vasopressors. The patient recovered gradually and was discharged home fifteen (15) days later.


Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2018

Preventing the development and progression of diabetic kidney disease: Where do we stand?

Georgios Zagkotsis; Maria P. Markou; Eleni Paschou; Panagiota Papanikolaou; Nikos Sabanis

Diabetic kidney disease (DKD) is a major factor associated with increased cardiovascular (CV) and all-cause mortality and morbidity in patients with diabetes. Current standard therapy includes intensive management of hyperglycemia and blood pressure control with renin-angiotensin-aldosterone system (RAAS) blockers. Despite the implementation of this strategy, DKD remains the leading cause of end-stage renal disease (ESRD), mainly because of the increasing burden of diabetes mellitus. The aim of this review is to evaluate the available evidence, focusing on the benefit of current treatment in the development and progression of DKD.


Saudi Journal of Kidney Diseases and Transplantation | 2016

Renal manifestations of human brucellosis: First report of minimal change disease

Nikolaos Sabanis; Eleni Gavriilaki; Eleni Paschou; Eleni Tsotsiou; Christos Kavlakoudis; Sotirios Vasileiou

Human brucellosis is considered a great example of the complexity of clinical manifestations possibly affecting multiple organs or systems. Renal manifestations of human brucellosis have been documented in few case reports and one case series. Herein, we present a case of Nephrotic syndrome (NS) due to minimal change disease in the course of acute brucellosis. A 53-year-old male farmer was admitted to our department with acute brucellosis and NS. Renal biopsy revealed minimal change disease. Combined treatment with prednisone (1 mg/kg), rifampicin (600 mg/day), and doxycycline (200 mg/day) was initiated. Complete remission of NS was achieved at the end of the fourth week. One year later, the patient remained in complete remission of NS without any sign of relapse of brucellosis.


Hemodialysis International | 2016

Acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis in a hemodialysis patient.

Nikos Sabanis; Eleni Paschou; Eleni Gavriilaki; Dimitrios Papanikolaou; Sotiris Vasileiou; Ioannis Amplianitis

Hemodialysis patients present with a broad spectrum of specific and nonspecific skin disorders, which rarely coexist. We report an exceptional case of a hemodialysis patient that developed acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis on the basis of common skin disorders which include hyperpigmentation, pruritus, xerosis cutis, and Linsdays nails. Interestingly, our patient presented with two unusual but distinctive cutaneous dermopathies on the background of other commonly seen skin alterations. The patient was successfully treated with allopurinol and N‐acetylcysteine. Avoidance of potentially triggering factors such as alcohol, sunlight exposure and certain medication was recommended. Thus, increasing clinical awareness, assiduous investigation and early treatment of skin disorders are required to improve the prognosis and quality of life in this patient population.


Case reports in nephrology | 2015

Unexpected Abscess Localization of the Anterior Abdominal Wall in an ADPKD Patient Undergoing Hemodialysis

Nikos Sabanis; Eleni Paschou; Eleni Gavriilaki; Maria Mourounoglou; Sotirios Vasileiou

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common monogenic disorders and the leading inheritable cause of end-stage renal disease worldwide. Cystic and noncystic extrarenal manifestations are correlated with variable clinical presentations so that an inherited disorder is now considered a systemic disease. Kidney and liver cystic infections are the most common infectious complications in ADPKD patients. Furthermore, it is well known that ADPKD is commonly associated with colonic diverticular disease which recently has been reported to be linked to increased risk of infection on hemodialysis patients. Herein, we present a case of anterior abdominal wall abscess caused by Enterococcus faecalis in a patient with ADPKD undergoing hemodialysis. Although the precise pathway of infection remains uncertain, the previous medical history as well as the clinical course of our patient led us to hypothesize an alternative route of infection from the gastrointestinal tract through an aberrant intestinal barrier into the bloodstream and eventually to an atypical location.

Collaboration


Dive into the Eleni Paschou's collaboration.

Top Co-Authors

Avatar

Eleni Gavriilaki

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Maria Mainou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Thomas Zarampoukas

Aristotle University of Thessaloniki

View shared research outputs
Researchain Logo
Decentralizing Knowledge